September 6, 2018 Synthetic Biologics Announces Agreement with Cedars-Sinai Medical Center for an Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C
August 30, 2018 Synthetic Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 8, 2018 Synthetic Biologics Reports Second Quarter 2018 Operational Highlights and Financial Results
July 31, 2018 Synthetic Biologics to Report Second Quarter 2018 Operational Highlights and Financial Results on August 8, 2018
May 8, 2018 Synthetic Biologics Reports First Quarter 2018 Operational Highlights and Financial Results
April 26, 2018 Synthetic Biologics to Report First Quarter 2018 Operational Highlights and Financial Results on May 8, 2018
April 23, 2018 Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection
